
Organovo Holdings ONVO
Quartalsbericht 2025-Q4
hinzugefügt 11.02.2026
Organovo Holdings Kurzfristige Verbindlichkeiten 2011-2026 | ONVO
Kurzfristige Verbindlichkeiten Jährlich Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.74 M | 1.86 M | 3.67 M | 721 K | 1.81 M | 3.74 M | 4.66 M | 6.01 M | 4.49 M | 4.76 M | 1.89 M | 8.38 M | 22 M | 1.98 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22 M | 721 K | 4.98 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
372 M | $ 17.01 | -0.09 % | $ 179 M | ||
|
Agilent Technologies
A
|
1.71 B | $ 117.69 | 0.14 % | $ 35.8 B | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 20.94 | 1.16 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Co-Diagnostics
CODX
|
3.54 M | $ 1.64 | 3.14 % | $ 2.18 M | ||
|
Castle Biosciences
CSTL
|
49.4 M | $ 24.75 | 0.61 % | $ 687 M | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
Medpace Holdings
MEDP
|
1.34 B | - | - | $ 12.3 B | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 181.73 | -1.97 % | $ 9.01 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Myriad Genetics
MYGN
|
134 M | $ 4.11 | -18.29 % | $ 381 M | ||
|
NeoGenomics
NEO
|
88.3 M | $ 8.89 | 0.34 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
36.6 M | $ 17.86 | -4.7 % | $ 400 M | ||
|
Natera
NTRA
|
310 M | $ 215.09 | 4.02 % | $ 21.2 B | ||
|
Fulgent Genetics
FLGT
|
72.9 M | $ 14.92 | 0.13 % | $ 451 M | ||
|
Personalis
PSNL
|
31.1 M | $ 6.07 | 9.17 % | $ 360 M | ||
|
Guardant Health
GH
|
303 M | $ 92.25 | 3.05 % | $ 11.6 B | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
61.4 M | $ 52.94 | 0.04 % | $ 2.69 B | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 124.13 | 2.32 % | $ 10.2 B | ||
|
Illumina
ILMN
|
1.55 B | $ 142.58 | 2.52 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
24.3 M | $ 5.36 | 7.2 % | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
5.1 M | - | - | $ 9.33 M | ||
|
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
15.2 B | $ 472.95 | 1.33 % | $ 178 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.21 | 1.14 % | $ 5.08 M | ||
|
Lantheus Holdings
LNTH
|
333 M | $ 86.15 | 0.38 % | $ 5.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 256.94 | -0.08 % | $ 21.4 B | ||
|
Twist Bioscience Corporation
TWST
|
91.4 M | $ 59.53 | 4.99 % | $ 3.56 B | ||
|
Celcuity
CELC
|
44.2 M | - | - | $ 6.52 B | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
174 M | $ 9.18 | -0.97 % | $ 1.99 B | ||
|
Waters Corporation
WAT
|
1.24 B | $ 349.53 | 1.98 % | $ 20.8 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 189.13 | -0.9 % | $ 21 B |